Cell Populations Which Co-Express Cd49C And Cd90

Patent No. EP1438392 (titled "Cell Populations Which Co-Express Cd49C And Cd90") was filed by Garnet Biotherapeutics on Sep 20, 2002. The application was issued on Jul 29, 2015.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ABT HOLDINGApr 29, 2016CORNISH

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP1438392

GARNET BIOTHERAPEUTICS
Application Number
EP02778303A
Filing Date
Sep 20, 2002
Status
Revoked
Apr 15, 2022
Publication Date
Jul 29, 2015